17 insiders reported 51 Form 4 transactions for Denali Therapeutics Inc. (DNLI) over the past 18 months (most recent 2026-06-05). Recent activity: Schenkein David P (Director) Buy 6,408 shares, Baker Bros. Advisors (GP) LLC (Director) Buy 6,408 shares, BAKER FELIX (Director) Buy 6,408 shares, FLATLEY JAY T (Director) Buy 6,408 shares, Baker Brothers Life Sciences LP (Director) Buy 6,408 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Schenkein David P | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Baker Bros. Advisors (GP) LLC | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER FELIX | Director | Buy | 6,408 | $0 |
| 2026-06-05 | FLATLEY JAY T | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Baker Brothers Life Sciences LP | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Klein Peter S | Director | Buy | 6,408 | $0 |
| 2026-06-05 | 667, L.P. | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Van Hauwermeiren Timothy | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Baker Bros. Advisors (GP) LLC | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Krognes Steve E. | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Cook Jennifer E. | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Thornberry Nancy | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER BROS. ADVISORS LP | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER FELIX | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER JULIAN | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER BROS. ADVISORS LP | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Baker Brothers Life Sciences LP | Director | Buy | 6,408 | $0 |
| 2026-06-05 | 667, L.P. | Director | Buy | 6,408 | $0 |
| 2026-06-05 | BAKER JULIAN | Director | Buy | 6,408 | $0 |
| 2026-01-08 | Watts Ryan J. | President and CEO | Sell | 35,198 | $580,767 |
| 2026-01-08 | Schuth Alexander O. | COFO and Secretary | Sell | 17,218 | $284,097 |
| 2026-01-05 | Schuth Alexander O. | COFO and Secretary | Buy | 57,700 | $0 |
| 2026-01-05 | Watts Ryan J. | President and CEO | Buy | 78,960 | $0 |
| 2025-11-06 | Van Hauwermeiren Timothy | Director | Buy | 10,632 | $0 |
| 2025-09-05 | Watts Ryan J. | President and CEO | Sell | 50,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05